The indispensable involvement of GRP78 in the GCS1-mediated promotion of CRC progression was further confirmed by representative images of subcutaneous xenograft tumors in nude mice, statistical analysis of the tumor weight and volume, and representative immunohistochemical images of tumors (Fig. 7P-S). The gene discussed is MOGS; the disease is colorectal carcinoma.